Clinical Trial Update: A 12-Week, Phase 2 Study of Gemcabene in Hypercholesterolemia Patients on Stable Moderate and High-Intensity Statins [Phase 2]

View source ↗

Summary

Phase 2 trial update for gemcabene in hypercholesterolemia patients on stable statin therapy has completed, with results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia

Drugs mentioned

• gemcabene (gemcabene)

Snippet

Sponsor: NeuroBo Pharmaceuticals Inc. | Conditions: Hypercholesteremia | Phase 2 | Status: COMPLETED | Results posted: 2020-06-25